Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: A randomised trial

Jee Yoong Leong, Juliana van der Merwe, Salvatore Pepe, Michael John Bailey, Tony Perkins, Robyn Lymbury, Donald Stephen Esmore, Silvana Marasco, Franklin Lawrence Rosenfeldt

Research output: Contribution to journalArticleResearchpeer-review

39 Citations (Scopus)


Perioperative therapy with antioxidants and metabolic substrates has the potential to reduce oxidative stress and improve recovery from cardiac surgery, particularly in elderly and high risk cases. The aim of this study was to assess the effect of perioperative metabolic therapy at a biochemical, clinical and economic level in cardiac surgical patients.Perioperative metabolic therapy for cardiac surgery is safe and inexpensive and is associated with improved redox status, reduced myocardial damage, and shortened length of postoperative hospital stay.
Original languageEnglish
Pages (from-to)584 - 591
Number of pages8
JournalHeart Lung and Circulation
Issue number10
Publication statusPublished - 2010

Cite this